This inventor holds 1 USPTO granted patent and 4 published patent applications and 2 EPO patents. Top assignee: Glaxosmithkline Intellectual Property Development Limited. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Michael Neil Burden - Innovator in Medical Therapy
Introduction
Michael Neil Burden is an accomplished inventor based in Stevenage, GB. He is currently associated with Glaxo Group Limited, where he contributes to advancements in medical therapies. Despite having no granted patents to his name, Burden is actively involved in innovative research and development.
Latest Patent Applications
Michael Neil Burden's latest patent applications include significant contributions to medical therapy. One of his applications is titled "CR2 Binding Proteins and their use in Medical Therapy." This invention provides CR2 binding proteins that bind to human CR2, along with pharmaceutical compositions comprising these proteins. They are intended for the treatment or prevention of autoimmune and inflammatory conditions, infectious diseases, and malignancies associated with the Epstein-Barr virus (EBV). Additionally, these proteins can be used as vaccine adjuvants and antigen carriers. Another application is for "Antigen-Binding Constructs," which relates to constructs comprising a protein scaffold linked to one or more epitope-binding domains. These constructs have at least two antigen binding sites, with at least one from an epitope binding domain and one from a paired VH/VL domain. The application also includes methods of making such constructs and their uses.
Conclusion
Michael Neil Burden is a dedicated inventor making strides in the field of medical therapy through his innovative patent applications. His work holds promise for advancements in treating various medical conditions.